Validity and Reliability of the Turkish Version of the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ)
Biruni University
50 participants
Aug 1, 2026
OBSERVATIONAL
Conditions
Summary
The aim of this methodological study is to translate the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ) into Turkish, culturally adapt it, and evaluate its validity and reliability for use in adults with brachial plexus birth palsy. The study will include 50 adult participants aged 18 years and older with a diagnosis of brachial plexus birth palsy. Participants will complete the Turkish version of the IMBPIQ, as well as the Disabilities of the Arm, Shoulder and Hand questionnaire and the Short Form-36. The psychometric properties of the Turkish IMBPIQ will be examined using reliability and validity analyses, including internal consistency, test-retest reliability, and construct validity.
Eligibility
Inclusion Criteria4
- Being 18 years of age or older.
- Having a diagnosis of brachial plexus birth palsy.
- Having the ability to read, write, speak, and understand Turkish.
- Agreeing to participate voluntarily in the study and signing the informed consent form.
Exclusion Criteria5
- Having a neurological disease.
- Having another orthopedic problem or a history of trauma in the affected upper extremity.
- Having a severe cognitive or communication impairment that may prevent completion of the questionnaires or understanding of the study instructions.
- Having a history of systemic disease requiring an acute attack or hospitalization within the last three months.
- Being pregnant or being in the postpartum period of less than 6 months.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will complete the Turkish version of the Impact of Brachial Plexus Injury Questionnaire, the Disabilities of the Arm, Shoulder and Hand questionnaire, and the Short Form-36.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07654504